Showing results (641-650 of 657) with videos related to

Sort By:
Pageof 66
Bioresource Technology|February 8, 2019
Investigation of reverse ionic diffusion in forward-osmosis-aided dewatering of microalgae: A molecular dynamics studyJester N Itliong, Al Rey C Villagracia, Joaquin Lorenzo V Moreno, et al.
The International Journal of Biochemistry & Cell Biology|May 12, 2009
Cloning and characterization of a novel intracellular protein p48.2 that negatively regulates cell cycle progressionFan Yang, Yu-Ping Xu, Jian Li, et al.
European Journal of Gastroenterology & Hepatology|December 4, 2025
Sintilimab as adjuvant therapy for high-risk hepatocellular carcinoma after curative resection: a multicentric retrospective cohort studyXiao-Ling Xu, Jia-Yong Su, Yi Zhang, et al.
Bioorganic & Medicinal Chemistry Letters|June 9, 2023
Discovery of novel pyridinones as MGAT2 inhibitors for the treatment of metabolic disordersFang Moore, Wei Wang, Guohua Zhao, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|June 16, 2025
Adjuvant Transarterial Chemoembolization After Truly Curative Resection Does Not Improve Survival of Patients With Hepatocellular Carcinoma at High Risk of Recurrence: A Target Trial Emulation StudyJia-Yong Su, De-Jia Huang, Shao-Ping Liu, et al.
United European Gastroenterology Journal|May 16, 2024
Optical enhancement mode 2 improves the detection rate of gastric neoplastic lesion in high-risk populations: A multicenter randomized controlled clinical studyWei An, Qi Wu, Xiao-Ju Su, et al.
Journal of Medicinal Chemistry|September 19, 2023
Discovery of <b>12</b> (BMS-986172) as a Highly Potent MGAT2 Inhibitor that Achieved Targeted Efficacious Exposures at a Low Human Dose for the Treatment of Metabolic DisordersWei Meng, Robert Brigance, James Mignone, et al.
Scientific Reports|June 2, 2026
Progression-free survival as a potential surrogate endpoint for overall survival after conversion therapy for unresectable hepatocellular carcinoma (GUIDANCE008)Jin-Wei Wu, Da-Long Yang, Shu-Chang Chen, et al.
Journal of Medicinal Chemistry|October 6, 2021
Screening Hit to Clinical Candidate: Discovery of BMS-963272, a Potent, Selective MGAT2 Inhibitor for the Treatment of Metabolic DisordersHuji Turdi, Hannguang Chao, Jon J Hangeland, et al.
Liver Cancer|June 11, 2025
Survival Benefit of Hepatectomy after Complete or Partial Response to Conversion Therapy in Unresectable Hepatocellular Carcinoma (GUIDANCE003): A Multicenter StudyDa-Long Yang, Ning Peng, Jun-Liang Nong, et al.
Pageof 66